BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27815347)

  • 1. The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations.
    Fuchs H; Sabrautzki S; Przemeck GK; Leuchtenberger S; Lorenz-Depiereux B; Becker L; Rathkolb B; Horsch M; Garrett L; Östereicher MA; Hans W; Abe K; Sagawa N; Rozman J; Vargas-Panesso IL; Sandholzer M; Lisse TS; Adler T; Aguilar-Pimentel JA; Calzada-Wack J; Ehrhard N; Elvert R; Gau C; Hölter SM; Micklich K; Moreth K; Prehn C; Puk O; Racz I; Stoeger C; Vernaleken A; Michel D; Diener S; Wieland T; Adamski J; Bekeredjian R; Busch DH; Favor J; Graw J; Klingenspor M; Lengger C; Maier H; Neff F; Ollert M; Stoeger T; Yildirim AÖ; Strom TM; Zimmer A; Wolf E; Wurst W; Klopstock T; Beckers J; Gailus-Durner V; Hrabé de Angelis M
    G3 (Bethesda); 2016 Dec; 6(12):4035-4046. PubMed ID: 27815347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a mouse Scube3 reporter line.
    Xavier GM; Economou A; Senna Guimarães AL; Sharpe PT; Cobourne MT
    Genesis; 2010 Dec; 48(12):684-92. PubMed ID: 20957652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.
    Lin YC; Niceta M; Muto V; Vona B; Pagnamenta AT; Maroofian R; Beetz C; van Duyvenvoorde H; Dentici ML; Lauffer P; Vallian S; Ciolfi A; Pizzi S; Bauer P; Grüning NM; Bellacchio E; Del Fattore A; Petrini S; Shaheen R; Tiosano D; Halloun R; Pode-Shakked B; Albayrak HM; Işık E; Wit JM; Dittrich M; Freire BL; Bertola DR; Jorge AAL; Barel O; Sabir AH; Al Tenaiji AMJ; Taji SM; Al-Sannaa N; Al-Abdulwahed H; Digilio MC; Irving M; Anikster Y; Bhavani GSL; Girisha KM; ; Haaf T; Taylor JC; Dallapiccola B; Alkuraya FS; Yang RB; Tartaglia M
    Am J Hum Genet; 2021 Jan; 108(1):115-133. PubMed ID: 33308444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones.
    Wu BT; Su YH; Tsai MT; Wasserman SM; Topper JN; Yang RB
    J Biol Chem; 2004 Sep; 279(36):37485-90. PubMed ID: 15234972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development.
    Tu CF; Tsao KC; Lee SJ; Yang RB
    J Biol Chem; 2014 Jul; 289(27):18928-42. PubMed ID: 24849601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scube3 is expressed in multiple tissues during development but is dispensable for embryonic survival in the mouse.
    Xavier GM; Panousopoulos L; Cobourne MT
    PLoS One; 2013; 8(1):e55274. PubMed ID: 23383134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, tissue expression pattern, and copy number variation of porcine SCUBE3.
    Liu X; Wang LG; Zhang LC; Yan H; Zhao KB; Liang J; Li N; Pu L; Zhang T; Wang LX
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Scube3 epidermal growth factor-related gene during early embryonic development in the mouse.
    Haworth K; Smith F; Zoupa M; Seppala M; Sharpe PT; Cobourne MT
    Gene Expr Patterns; 2007 Apr; 7(5):630-4. PubMed ID: 17258941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1
    Kumar S; Rathkolb B; Sabrautzki S; Krebs S; Kemter E; Becker L; Beckers J; Bekeredjian R; Brommage R; Calzada-Wack J; Garrett L; Hölter SM; Horsch M; Klingenspor M; Klopstock T; Moreth K; Neff F; Rozman J; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Wolf E; Aigner B
    J Biomed Sci; 2017 Aug; 24(1):57. PubMed ID: 28818080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of SCUBE.
    Lin YC; Sahoo BK; Gau SS; Yang RB
    J Biomed Sci; 2023 May; 30(1):33. PubMed ID: 37237303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice.
    Yang HY; Cheng CF; Djoko B; Lian WS; Tu CF; Tsai MT; Chen YH; Chen CC; Cheng CJ; Yang RB
    Cardiovasc Res; 2007 Jul; 75(1):139-47. PubMed ID: 17442284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing identifies a nonsense mutation in Fam46a associated with bone abnormalities in a new mouse model for skeletal dysplasia.
    Diener S; Bayer S; Sabrautzki S; Wieland T; Mentrup B; Przemeck GK; Rathkolb B; Graf E; Hans W; Fuchs H; Horsch M; Schwarzmayr T; Wolf E; Klopocki E; Jakob F; Strom TM; Hrabě de Angelis M; Lorenz-Depiereux B
    Mamm Genome; 2016 Apr; 27(3-4):111-21. PubMed ID: 26803617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
    Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
    Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel missense mutation of uromodulin in mice causes renal dysfunction with alterations in urea handling, energy, and bone metabolism.
    Kemter E; Rathkolb B; Rozman J; Hans W; Schrewe A; Landbrecht C; Klaften M; Ivandic B; Fuchs H; Gailus-Durner V; Klingenspor M; de Angelis MH; Wolf E; Wanke R; Aigner B
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1391-8. PubMed ID: 19692485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Standardized, Systemic Phenotypic Analysis of Pou3f3L423P Mutant Mice.
    Kumar S; Rathkolb B; Kemter E; Sabrautzki S; Michel D; Adler T; Becker L; Beckers J; Busch DH; Garrett L; Hans W; Hölter SM; Horsch M; Klingenspor M; Klopstock T; Rácz I; Rozman J; Vargas Panesso IL; Vernaleken A; Zimmer A; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Wolf E; Aigner B
    PLoS One; 2016; 11(3):e0150472. PubMed ID: 27003440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype.
    Chong B; Hegde M; Fawkner M; Simonet S; Cassinelli H; Coker M; Kanis J; Seidel J; Tau C; Tüysüz B; Yüksel B; Love D;
    J Bone Miner Res; 2003 Dec; 18(12):2095-104. PubMed ID: 14672344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences.
    Hocking LJ; Lucas GJ; Daroszewska A; Cundy T; Nicholson GC; Donath J; Walsh JP; Finlayson C; Cavey JR; Ciani B; Sheppard PW; Searle MS; Layfield R; Ralston SH
    J Bone Miner Res; 2004 Jul; 19(7):1122-7. PubMed ID: 15176995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular pathogenesis of Paget disease of bone.
    Layfield R
    Expert Rev Mol Med; 2007 Oct; 9(27):1-13. PubMed ID: 17903332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
    Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
    Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.